Bio-Rad Laboratories Class B
BIO.B
9 hedge funds and large institutions have $6.8M invested in Bio-Rad Laboratories Class B in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.16% less ownership
Funds ownership: 0.52% → 0.36% (-0.16%)
25% less capital invested
Capital invested by funds: $9.05M → $6.8M (-$2.25M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GI
GAMCO Investors
Greenwich,
Connecticut
|
+$201K |
| 2 |
Renaissance Technologies
New York
|
+$35.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CSS LLC
Chicago,
Illinois
|
-$3.08M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $5.02M | -$3.08M | -8,722 | -39% |
|
|
CF
2
Copperwynd Financial
Scottsdale,
Arizona
| $657K | – | – | – |
|
|
3
Renaissance Technologies
New York
| $480K | +$35.3K | +100 | +8% |
|
4
UBS Group
Zurich,
Switzerland
| $212K | – | – | – |
|
|
GI
5
GAMCO Investors
Greenwich,
Connecticut
| $211K | +$201K | +570 | New |
|
6
Morgan Stanley
New York
| $193K | – | – | – |
|
7
Wells Fargo
San Francisco,
California
| $21K | – | – | – |
|
8
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
BIO.B Hedge Fund Activity: Q4 2019 in Review
9 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q4 2019, worth a combined $6.8M — down 25% from $9.05M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIO.B positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was GAMCO Investors, opening a new position worth an estimated $201K. The largest seller was CSS LLC, cutting an estimated $3.08M.
- 9 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $6.8M of Bio-Rad Laboratories Class B stock for Q4 2019, down 25% quarter-over-quarter.
- 1 fund opened new Bio-Rad Laboratories Class B positions in Q4 2019 and 0 closed out, a net change of +1 holder.
- The largest Bio-Rad Laboratories Class B buyer in Q4 2019 was GAMCO Investors, an estimated $201K added.
- The largest Bio-Rad Laboratories Class B seller in Q4 2019 was CSS LLC, an estimated $3.08M sold.
Based on aggregated 13F filings for Q4 2019.